FR2925051B1 - Derives d'azetidines,leur preparation et leur application en therapeutique - Google Patents

Derives d'azetidines,leur preparation et leur application en therapeutique

Info

Publication number
FR2925051B1
FR2925051B1 FR0708830A FR0708830A FR2925051B1 FR 2925051 B1 FR2925051 B1 FR 2925051B1 FR 0708830 A FR0708830 A FR 0708830A FR 0708830 A FR0708830 A FR 0708830A FR 2925051 B1 FR2925051 B1 FR 2925051B1
Authority
FR
France
Prior art keywords
preparation
therapeutic use
azetidine derivatives
azetidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0708830A
Other languages
English (en)
Other versions
FR2925051A1 (fr
Inventor
Jean Francois Sabuco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0708830A priority Critical patent/FR2925051B1/fr
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Priority to ES08872952.0T priority patent/ES2439258T3/es
Priority to BRPI0822054-9A priority patent/BRPI0822054A2/pt
Priority to KR1020107015774A priority patent/KR20100098563A/ko
Priority to PT88729520T priority patent/PT2234966E/pt
Priority to EP08872952.0A priority patent/EP2234966B1/fr
Priority to PL08872952T priority patent/PL2234966T3/pl
Priority to PCT/FR2008/001748 priority patent/WO2009106708A2/fr
Priority to SI200831115T priority patent/SI2234966T1/sl
Priority to AU2008351943A priority patent/AU2008351943B2/en
Priority to JP2010538830A priority patent/JP5460614B2/ja
Priority to DK08872952.0T priority patent/DK2234966T3/da
Priority to ARP080105459A priority patent/AR069700A1/es
Priority to CA2709863A priority patent/CA2709863A1/fr
Priority to EA201070758A priority patent/EA019315B1/ru
Priority to PE2008002084A priority patent/PE20091270A1/es
Priority to CN200880126985.5A priority patent/CN101945852B/zh
Priority to PA20088808101A priority patent/PA8808101A1/es
Priority to CL2008003780A priority patent/CL2008003780A1/es
Priority to TW097149442A priority patent/TW200930360A/zh
Priority to UY31548A priority patent/UY31548A1/es
Publication of FR2925051A1 publication Critical patent/FR2925051A1/fr
Application granted granted Critical
Publication of FR2925051B1 publication Critical patent/FR2925051B1/fr
Priority to IL206420A priority patent/IL206420A/en
Priority to US12/818,274 priority patent/US8445478B2/en
Priority to CO10073795A priority patent/CO6290755A2/es
Priority to MA33018A priority patent/MA32019B1/fr
Priority to HK11106128.9A priority patent/HK1152038A1/xx
Priority to US13/868,602 priority patent/US20130237513A1/en
Priority to HRP20131168AT priority patent/HRP20131168T1/hr
Priority to CY20131101118T priority patent/CY1114991T1/el
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0708830A 2007-12-18 2007-12-18 Derives d'azetidines,leur preparation et leur application en therapeutique Expired - Fee Related FR2925051B1 (fr)

Priority Applications (29)

Application Number Priority Date Filing Date Title
FR0708830A FR2925051B1 (fr) 2007-12-18 2007-12-18 Derives d'azetidines,leur preparation et leur application en therapeutique
EA201070758A EA019315B1 (ru) 2007-12-18 2008-12-16 Производные азетидинов, их получение и применение в терапии
KR1020107015774A KR20100098563A (ko) 2007-12-18 2008-12-16 아제티딘 유도체, 그의 제법 및 치료에서의 그의 적용
PE2008002084A PE20091270A1 (es) 2007-12-18 2008-12-16 Derivados de azetidinas con actividad sobre receptores cb1 y su preparacion
EP08872952.0A EP2234966B1 (fr) 2007-12-18 2008-12-16 Derives d'azetidines, leur preparation et leur application en therapeutique
PL08872952T PL2234966T3 (pl) 2007-12-18 2008-12-16 Pochodne azetydyn, ich wytwarzanie i zastosowanie ich w lecznictwie
PCT/FR2008/001748 WO2009106708A2 (fr) 2007-12-18 2008-12-16 Derives d'azetidines, leur preparation et leur application en therapeutique
BRPI0822054-9A BRPI0822054A2 (pt) 2007-12-18 2008-12-16 Derivados de azetidinas, o respectivo preparo e a respectiva aplicação em terapêutica
AU2008351943A AU2008351943B2 (en) 2007-12-18 2008-12-16 Azetidine derivatives, their preparation and their application in therapy
JP2010538830A JP5460614B2 (ja) 2007-12-18 2008-12-16 アゼチジン誘導体、それらの調製、およびそれらの治療における適用
DK08872952.0T DK2234966T3 (da) 2007-12-18 2008-12-16 Azetidinderivater, fremstilling og terapeutisk anvendelse heraf
ARP080105459A AR069700A1 (es) 2007-12-18 2008-12-16 Derivados de azetidina,composiciones farmaceuticas que los comprenden, metodo de preparacion, intermediarios de sintesis,y usos de los mismos en el tratamiento o prevencion de trastornos psiquiatricos , del sistema inmune y gastrointestinales, entre otros.
CA2709863A CA2709863A1 (fr) 2007-12-18 2008-12-16 Derives d'azetidines, leur preparation et leur application en therapeutique
SI200831115T SI2234966T1 (sl) 2007-12-18 2008-12-16 Derivati azetidinov, njihova priprava in njihova terapevtska uporaba
ES08872952.0T ES2439258T3 (es) 2007-12-18 2008-12-16 Derivados de azetidina, su preparación y su aplicación en terapia
CN200880126985.5A CN101945852B (zh) 2007-12-18 2008-12-16 氮杂环丁烷衍生物、其制备和其在治疗中的应用
PT88729520T PT2234966E (pt) 2007-12-18 2008-12-16 Derivados de azetidinas, sua preparação e sua aplicação em terapia
CL2008003780A CL2008003780A1 (es) 2007-12-18 2008-12-17 Compuestos derivados de azetidinas; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso para el tratamiento o la prevencion de trastornos psiquiatricos, dependencia o deshabituacion a una sustancia, trastornos cognitivos, enfermedades neurodegenerativas, entre otras.
PA20088808101A PA8808101A1 (es) 2007-12-18 2008-12-17 Derivados de azetidinas, su preparacion y su aplicacion en terapeutica
UY31548A UY31548A1 (es) 2007-12-18 2008-12-18 Derivados de azetidinas, su preparacion y su aplicacion en terapéutica
TW097149442A TW200930360A (en) 2007-12-18 2008-12-18 Azetidine derivatives, preparation thereof and therapeutic use thereof
IL206420A IL206420A (en) 2007-12-18 2010-06-16 Aztidine derivatives, their preparation, intermediates for their preparation, pharmaceutical preparations containing them and their use in the preparation of medicines
US12/818,274 US8445478B2 (en) 2007-12-18 2010-06-18 Azetidine derivatives, their preparation and their application in therapy
CO10073795A CO6290755A2 (es) 2007-12-18 2010-06-18 Derivados de azetidinas su preparacion y su aplicacion en terapeutica
MA33018A MA32019B1 (fr) 2007-12-18 2010-07-14 Derives d'azetidines, leur preparation et leur application en therapeutique
HK11106128.9A HK1152038A1 (en) 2007-12-18 2011-06-15 Azetidine derivatives, their preparation and their application in therapy
US13/868,602 US20130237513A1 (en) 2007-12-18 2013-04-23 Azetidine derivatives, their preparation and their application in therapy
HRP20131168AT HRP20131168T1 (hr) 2007-12-18 2013-12-10 Derivati azetidina, njihovo dobivanje i njihova terapijska primjena
CY20131101118T CY1114991T1 (el) 2007-12-18 2013-12-11 Παραγωγα αζετιδινων, ο τροπος παρασκευης τους και η εφαρμογη τους στη θεραπευτικη

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0708830A FR2925051B1 (fr) 2007-12-18 2007-12-18 Derives d'azetidines,leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2925051A1 FR2925051A1 (fr) 2009-06-19
FR2925051B1 true FR2925051B1 (fr) 2010-05-21

Family

ID=39345539

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0708830A Expired - Fee Related FR2925051B1 (fr) 2007-12-18 2007-12-18 Derives d'azetidines,leur preparation et leur application en therapeutique

Country Status (1)

Country Link
FR (1) FR2925051B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004234125A1 (en) * 2003-05-01 2004-11-11 Vernalis Research Limited Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders
PE20071092A1 (es) * 2005-12-08 2007-12-10 Aventis Pharma Inc Composicion farmaceutica que comprende un antagonista de cb1 y un agente antisicotico

Also Published As

Publication number Publication date
FR2925051A1 (fr) 2009-06-19

Similar Documents

Publication Publication Date Title
FR2911604B1 (fr) Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2910473B1 (fr) Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
FR2882054B1 (fr) Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
MA28734B1 (fr) Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique
FR2903985B1 (fr) Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2904316B1 (fr) Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
MA28575B1 (fr) Derives de la 1-amino-phthalazine, leur preparation , et leur application en therapeutique
FR2915198B1 (fr) Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
FR2928149B1 (fr) Composes derives d'azetidines, leur preparation et leur application en therapeutique
MA28343A1 (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
FR2915199B1 (fr) Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
MA29017B1 (fr) Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
FR2885364B1 (fr) Derives d'alkyl-, alkenyl-et alkynylcarbamates, leur preparation et leur application en therapeutique
FR2873691B1 (fr) Derives d'amino-piperidine, leur preparation et leur application en therapeutique
FR2888847B1 (fr) Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique
FR2917412B1 (fr) Derives de 7-alkynyl, 1,8-naphthyridones, leur preparation et leur application en therapeutique
FR2934995B1 (fr) Composes d'azetidines polysubstitues, leur preparation et leur application en therapeutique
FR2866888B1 (fr) Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en therapeutique
FR2934265B1 (fr) Derives de carbamates d'alkylthiazoles, leur preparation et leur application en therapeutique
FR2915197B1 (fr) Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
FR2920023B1 (fr) Derives de l'indol-2-one disubstitues en 3, leur preparation et leur application en therapeutique
FR2888848B1 (fr) Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2891825B1 (fr) Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique
FR2866885B1 (fr) Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique
FR2917413B1 (fr) Derives de 7-alkynyl-1,8-naphthyridones, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160831